INTRODUCTION
"Pre-eclampsia is a multisystem disorder that is usually associated with raised blood pressure and proteinuria but, when severe, may cause pathology of the women's liver, kidneys, clotting system, and brain. The placenta is also involved with increased risk or poor growth and early delivery for the baby. It is a relatively common complication of pregnancy, and can occur at any time during the second half of pregnancy or the first few weeks after delivery… Eclampsia, defined as the occurrence of one or more convulsions (fits) in association with the syndrome of pre-eclampsia, is a rare but serious complication" (Duley, Gulmezoglu & Henderson-Smart, 2000:1) . Eclampsia is a condition peculiar to pregnant or newly delivered patients. It is characterised by convulsions, which occur as a result of raised blood pressure associated with pregnancy (WHO, 1996:14) . At the hospital where this research was conducted no distinction was made between eclampsia and pre-eclampsia. Consequently this research used the term severe pre-eclampsia/ eclampsia as indicating the total range of women affected by this condition. The diagnoses in the patients' records were accepted as indicating whether or not any specific woman suffered from severe preeclampsia/eclampsia.
The high maternal mortality ratio (MMR), calculated as the number of maternal deaths divided by the number of live births (WHO, 1996:99) in developing countries, remains a major global concern. Every year 600 000 women die from causes associated with pregnancy and childbirth (WHO, 1999:1) . Almost 90.0 percent of these global maternal deaths occur in Sub-Sahara Africa (SSA) and Asia (Starrs, 1997:1) . While women in Northern Europe have a 1:4 000 chance of dying from pregnancy related complications, those in Africa have a 1:16 chance (Starrs, 1997:1) . This scenario depicts maternal mortality as a sensitive indicator of inequality in socio-economic status and the disparities between the developed countries and Africa. Bennett and Brown (1999:692) define maternal mortality as a death that occurs as a result of pregnancy or childbirth complications or as a consequence of pregnancy within 42 days after delivery or abortion.
A Zimbabwean study by Ashworth (1990:211) indicates that abortion, severe pre-eclampsia/eclampsia, obstetric (including ante-, intra-and post-partum) haemorrhage, obstructed labour and puerperal sepsis are the leading causes of maternal deaths. Post-abortion complications and severe pre-eclampsia/eclampsia account for the majority of the global obstetric deaths (WHO, 1999:13) . Severe pre-eclampsia/eclampsia accounts for 10 to 15 percent of the total maternal deaths in developing countries (AbouZahr & Royston, 1991:8) . According to Duley et al. (2000:2) pre-eclampsia/eclampsia complicates one in 100 deliveries in developing countries and accounts for approximately 10 percent of direct maternal deaths globally. In Zimbabwe, at Mpilo Central Referral Hospital (MCRH) in Bulawayo, out of 116 reported obstetric deaths, 24 (20.7 percent) of these deaths were due to severe preeclampsia/eclampsia (MCRH Obstetric Records 1994 . In the same period puerperal sepsis accounted for 12.9 percent, haemorrhage for 12.1 percent and other obstetric complications for 14.6 percent of obstetric deaths. Thus investigating factors contributing to maternal deaths among women suffering from severe pre-eclampsia/eclampsia would also address factors contributing to large numbers of maternal deaths, and ultimately help to reduce these numbers.
According to a United Kingdom (UK) report (Department of Health, 1994:iv) on confidential enquiries into maternal mortalities in the UK, women often died when the care they received was substandard. The fact that some high-risk women died and others survived was the reason why this study was conducted, in order to identify factors discriminating between non-surviving (cases) and surviving (controls) women hospitalised at MCRH with severe pre-eclampsia/eclampsia. The study intended to establish whether the quality of care those women received influenced their chances of surviving obstetric complications. The purpose of the study was to identify factors associated with maternal mortality among non-surviving (cases) and surviving (controls) women hospitalised for severe pre-eclampsia/ eclampsia at MCRH from 1 January 1995 until 31 December 1997.
The research questions, which guided this research, were:
· Is there a difference in selected physiological factors associated with maternal mortality due to severe pre-eclampsia/eclampsia between non-surviving (cases) and surviving (controls) women hospitalised at MCRH during 1995 MCRH during , 1996 MCRH during and 1997 · Is there a difference in selected aspects of the standard of maternity care received by nonsurviving (cases) and surviving (controls)
women hospitalised for severe pre-eclampsia/ eclampsia at MCRH during 1995 MCRH during , 1996 MCRH during and 1997 The following hypotheses were advanced for this study: 
LITERATURE REVIEW
Studies of maternal mortality show that every year over half a million women world-wide die in and around childbirth and that 99.0 percent of these deaths occur in the developing countries (AbouZahr & Royston, 1991:1; WHO, 1995:1) . For every woman who dies, a further 10 to 16 are handicapped or suffer from serious chronic illnesses subsequent to the delivery of their babies. Some women eventually die from these chronic conditions (Downe, 1991:33; Paul, 1993:745) . It is estimated that 55 percent of the world's maternal deaths occur in Asia and Africa (WHO, 1995:2) . About 150 000 deaths occur annually in SSA, with extremely high ratios (over 1000 per 100 000 live births) in the Eastern and Western regions of Africa (Howson, Harrison, Hotra & Law, 1996:85; WHO, 1995:2) .
The Nurses' Association of American College of Obstetricians and Gynaecologists (NAAOG) refers to quality as a "… state of agreed-upon excellence" (NAAOG, 1990:2) . Definitions of quality emphasise characteristic features of excellence and clinical standards. Effectiveness reflects the degree of achieved desired effects such as a reduction in mortality and morbidity rates.
On the other hand, efficacy as an outcome of care, refers to benefits received by individual consumers of health care (Abramson, 1990:49) .
Two important factors for assessing the quality of care are standards and criteria and their vital role in clinical practice for achieving desired maternity care outcomes.
As the NAAOG (1990:20) states "… standards are a consensus agreement regarding the level of excellence of care." They also possess a legal aspect, which imposes binding responsibilities for which care-providers have to be accountable (Lindberg, Hunter & Kruszewski, 1994:53) . Bennett and Brown (1999:117) 
Hypertensive disorders of pregnancy
In medical terminology "blood pressure" describes the pressure of blood in the aorta and the large arteries that branch from it (Schauf, Moffett & Moffett, 1990:338) . Two measurements (systolic and diastolic pressures) indicate the two values of the blood pressure. The systolic pressure refers to the ejection phase of the cardiac cycle while the diastolic pressure is the minimum value of the ventricular diastole (Schauf et al. 1990:338) . vasoconstriciton reducing the blood supply across the placenta, and placental abruption…" (Duley & Henderson-Smart, 2000a :2).
According to Wallenburg (1989:382) showed that 20.0 percent of all the deaths were eclampsia-related (Khan, Jahan & Begum, 1986:11 According to Surratt (1993:501) , uncontrolled severe pre-eclampsia/eclampsia often results in a multisystem vasospasm and endothelial damage. This results in widespread ischaemic lesions in the vital organs with resultant death. The major final cause of death due to hypertension in pregnancy (in South Africa) was reportedly intracranial haemorrhage, followed by rupture of the liver and post-partum haemorrhage (Moodley, 1998:29) . The multisystem condition referred to as the HELLP syndrome is characterised by haemolysis (H), elevated liver (EL) enzymes and low platelet (LP) count (Poole, 1995:557; Sibai, Ramadan, Usta, Salam, Mercer & Friedman, 1993 :1000 phate is cheap and relatively easy to produce, and so making it readily available for the care of women with eclampsia in both developed and developing countries should be a high priority" (Duley & Henderson-Smart, 2000b:4) .
However, nurses and midwives must be alert because magnesium sulphate can cause toxicity (Lloyd & Lewis, 1999:324) . Magnesium sulphate is known to induce loss of patellar reflexes, while lethargy and respiratory depression are observed above eight (8) mEq/L, and cardiac arrest may appear at levels above 12 m/Eq/L (Kaplan & Repke, 1994:574) .
For women with DIC, treatment essentially focuses on correcting clotting factors by giving frozen plasma, fresh blood or platelet concentrates (Craft, 1999:267) .
Women suspected to be suffering from both HELLP syndrome and DIC might benefit from combined treatments, in addition to supportive therapy in terms of assessment and surveillance.
Quality obstetric To be effective in reducing maternal mortality levels, risk factors associated with women dying from pregnancy related complications, such as severe pre-eclampsia/eclampsia must be examined.
RESEARCH METHODOLOGY

Research Design
A retrospective unmatched case-control design was used to compare two groups (cases who died and controls who survived) of women admitted at the MCRH from 1 January 1995 to 31 December 1997, with severe pre-eclampsia/eclampsia. The population comprised 173 admissions for severe pre-eclampsia/eclampsia. There were 24 recorded maternal deaths associated with severe pre-eclampsia/eclampsia.
Sample size and sampling technique
The sample was drawn from hospital obstetric records of women who were admitted with severe pre-eclampsia/eclampsia. Twenty-four severe pre-eclampsia/eclampsia maternal deaths were identified, making it the second most important cause (superceded only by post-abortion complications) of maternal deaths during the research period at MCRH. From this population of 24 maternal deaths due to severe pre-eclampsia/eclampsia, 21 (87.5 percent) patients' records could be retrieved from MCRH's filing system. For each case (a woman who died from severe pre-eclampsia/eclampsia), records of two controls (women who survived this condition) were retrieved, as discussed under the data collection.
Research setting
The study site was MCRH in Bulawayo, which is the Two operating theatres with five recovery/high dependency beds (three adult beds and two incubators) form additional physical structures attached to the maternity unit. In 1995 and 1996, the bed occupancy rates were 99.9 and 84.5 percent respectively (MCRH Annual Report, Zimbabwe, 1996:9). The average length of stay was 3.9 days. The maternity unit's labour ward, delivers, on average, 12 000 babies annually, or about 1 000 babies per month, or more than 30 babies daily (MCRH Health Information Unit, 1995 .
The census conducted to provide background information to this study, revealed that there were, over the three-year period, 135 maternal deaths recorded of which 116 (85.9 percent) were maternal deaths due to obstetric complications. The majority of the obstetric deaths were due to abortion (39.6 percent) and severe pre-eclampsia/eclampsia (20.7 percent 
Research instruments
The hospital obstetrics census form and an obstetric record audit form were used to collect data. The hospital obstetrics census form collected data about the background information required to contextualise the research results of the study. The obstetric record audit form was used to obtain data required from the preeclampsia/eclampsia cases and controls. An experienced masters prepared midwifery lecturer, two statisticians from the University of Zimbabwe, and two nurse researchers from the University of South Africa, assessed the face validity of the items included in the obstetric record audit form. Modifications were made following the recommendations based on the first review. The format was then re-submitted to these experts for further reviews until there was more than 80 percent agreement on the relevancy of the items contained in the audit form (Talbot, 1995:282) . The instrument was pre-tested with the obstetric records of five cases and ten controls admitted with severe pre-eclampsia/eclampsia at MCRH during 1994. (These records were excluded from the survey which covered the period 1 January 1995 to 31 December 1997).
Pretesting of the checklists indicated that more specific categories should be created and that spaces should be provided for writing down additional information. This was done prior to embarking on the actual data collection phase.
The census data included information on annual ad- 
Ethical issues
Approval for the research was requested from and (cases') relatives. The study inflicted no harm on the subjects nor on their relatives as no names were disclosed at any stage to ensure confidentiality and anonymity. A coding system was used to ensure anonymity of patients and the data collected were used strictly for the purpose it was collected for. No specific person was mentioned in the discussion of the findings.
Data collection procedure
Data collection was carried out in phases addressing structure and process evaluation by means of the instruments developed to obtain the intended data. Information about the obstetric census variables was retrieved from the maternity unit's register for the period 1995, 1996 and 1997. The cases' and the controls' hospital numbers were identified from the admission and death registers. This information enabled the retrieval of the cases' and controls' obstetric records from the hospital medical records office. These records were subjected to thorough scrutiny in a separate office not accessible to anyone except the investigator and research assistant. Each case was given a code number, which it shared with its selected two controls to avoid using the same controls more than once (for example case = 1, controls = 1a and 1b). These codes served to ensure anonymity throughout the research process. The lack of access to specific patients' files made matching each case with two controls for age, parity, diagnosis and haemoglobin status impossible.
After consultation with statisticians it was decided to compare the data from two groups (cases versus controls) rather than the initially planned comparison of each case with two specific controls. Thus the data obtained from all cases constituted one category of data to be compared to the data obtained from all controls.
Attempts to randomly select controls had to be abandoned due to a large number of missing files which could not be traced. The only possibility which remained was to continue requesting the files of all possible controls until 42 such files were obtained, amounting to convenience sampling of the controls. Thus the number of cases amounted to 21 (n = 21) and the controls to 42 (n = 42).
Data analysis
The data was organised for analysis under severe preeclampsia/eclampsia cases and controls. Odds Ratio (OR) and 95 percent confidence interval (95% CI) were estimated according to the Mantel-Haenszel ChiSquare Test or Fischer's Exact Test (Kahn & Sempos, 1989:155) . A separate analysis was performed using stepwise logistic regression to take into account the effect of potentially confounding variable of residence, age, marital status and occupation status. The OR was used to measure the impact of a possible risk factor.
Possible categories for OR were greater than one or less than one (Kahn & Sempos, 1989:56) . When the value of OR was greater than one, there was a significant increased risk between maternal mortality due to severe pre-eclampsia/eclampsia and the factor.
On the other hand, when the OR was less than one the risk was reduced. This implied that there was no association between maternal death due to severe preeclampsia/eclampsia and the measured particular factor in cases where the OR was less than one (Kahn & Sempos, 1989:56) .
Univariate descriptive statistics, defined by Polit and Hungler (1995:657) as statistical procedures for analysing a single variable for purposes of description, were used to analyse data from socio-demographic, physiological, obstetrical/gynaecological and health service factors (Jacobsen, 1997:30 (Munro, 1997:292) .
RESEARCH RESULTS
The total sample comprised 21 pre-eclampsia/eclampsia cases and 42 controls, amounting to a total of 63 records which were analysed.
Socio-demographic factors
Variables categorised under socio-demographic factors included urban-rural residence, age, marital status, educational and employment status.
Urban-rural residence
In both cases and controls, the majority (95.2 and 90.5 percent respectively) were urban residents. The number of cases (95.2 percent) who were from the urban setting was almost similar in distribution to that of the controls (90.5 percent). The maternal mortality risk was not significantly increased by place of residence (p-value = 0.455, OR = 2.11, 95% CI = 0.19-3.85).
Age
The ages of both groups combined ranged from 15 to 49 years. The mean age was 24.9 for the cases and 25.7 for controls. Of the cases, 61.9 percent were between 20 and 29 years of age, while 38. 
Marital status
The women who were married were equally distributed among cases (76.2) and controls (76.2 percent). Marital status did not contribute to the risk of maternal mortality due to severe pre-eclampsia/eclampsia (p-value = 0.715, OR = 1.00, 95% CI = 0.23-2.79).
Educational status
When the educational background of the cases and controls was compared, there was a slightly higher 
Employment status
With respect to formal employment, 100.0 percent of the cases and 90.5 percent of the controls were not in formal employment suggesting that these women were possibly depending on their husbands or other family members for financial support. Hb level < 11.00 g/dl, DBP >110 mmHg and mean DBP >120 mmHg were the exposure variables 
Physiological factors
Haemoglobin level
Fourteen (66.7 percent) of the 21 cases had a haemoglobin level of <11 g/dl compared to 21 (50.0 percent) of the 42 controls indicating the prevalence of anaemia in both groups. The mean Hb level was 9.3 g/dl for the cases and 12.8 g/dl for the controls, with ranges from 3 to 14 for cases and 6 to 14 for controls.
Thus, the cases apparently had a lower Hb than the controls. When the risk of maternal mortality was analysed according to Hb level, women who were anaemic (Hb = <11 g/dl) had the same chance of survival as those whose haemoglobin level was normal (Hb = >11) if they developed severe pre-eclampsia/ eclampsia (p-value = 0.213, OR = 2.00, 95% CI = 0.60-7.05). There were more cases (66.7 percent) than controls (50.0 percent) who were anaemic.
Blood pressure level
The DBP ranged from 82 to 150 mm Hg in the cases and from 100 to 170 mm Hg in the controls. The mean for the cases was 119.6 mm Hg and for the controls it was 126 mm Hg. However, the median was 120 mm Hg in both groups with modes of 110 mm Hg for the cases and 120 mm Hg for controls as shown in The implication of this finding is that health care workers must do everything in their power to keep these women's diastolic blood pressures below 120 mm Hg in order to enhance their chances of survival.
Obstetric factors
The two most important factors investigated under this heading were gravidity and gestational period.
Gravidity
Gravidity for both the cases and the controls showed that the most affected group was primigravidae (42.9 percent of cases, 54.8 percent of controls) and gravid > four (43.3 percent of cases, 31.0 percent of controls) comprised the second largest group. The mean gravid for cases was 2.6, compared to the controls' mean of 2.5. There was no statistically significant difference in maternal mortality between women who were below or above gravida three (p-value = 0.847, OR = 0.89, 95% CI = 0.23-3.18).
Gestational period
The gestational period was considered in relation as to whether pregnancy was at term (40 weeks' gestation) or below term (preterm) up to 39 weeks' gestation. In cases, severe pre-eclampsia/eclampsia occurred more frequently at term than before term (57.1 percent) while were assessed daily by doctors, this aspect was excluded from the analysis as no differences would be detected.
Antenatal care
Out 
Records of fluid intake/output
Three ( 
The performance of caesarian sections
The majority of severe pre-eclampsia/eclampsia cases 
Emergency care
Analysis of emergency care showed that, of the 21 
Completeness of patients' records
Fifteen (71.4 percent) of the cases had evidence of complete records of care provided compared to 28.6 percent of the controls. Documentation of care that was provided for women with severe pre-eclampsia/ eclampsia was dichotomised for analysis according to two variables of "complete" or "incomplete". The results
showed that there was a statistically significant difference between women who had "complete" documentation of the care they received, with those who did not (p-value = 0.001) The OR of 0.16 suggests that women who had complete documentation of the care they received were more likely to die than those with incomplete records of care received. The 95% CI of 0.04-0.58 for the OR (excluding 1) further supports the statistical evidence that women who had "complete" documentation of the care they received, were more likely to die than those who had "incomplete" records.
Follow-up care
The follow-up care (one to four hourly monitoring of BP, temperature, respiration and pulse) was associated with increased risk of maternal mortality in women with severe pre-eclampsia/eclampsia. The p-value of 0.001
showed that there was a statistically significant difference in death due to severe pre-eclampsia/ eclampsia between women who were given follow-up care and those who did not receive this care. The OR of 0.16 suggests that women with severe preeclampsia/eclampsia who were given follow-up care
were more likely to die than those who were not provided with this care. The 95% CI of 0.04-0.16 for the OR (excluding 1) confirms the suggestion that women who received follow-up care had less chances of surviving than those whose records showed omissions of such follow-up care.
DISCUSSION OF RESEARCH RESULTS IN TERMS OF HYPOTHESES TESTED
The two-tailed test for normal distributions was used to Comparison between severe preeclampsia/eclampsia cases and controls by diastolic blood pressure level, proportion and p-value
The variables for physiological factors included in the analysis were DBP and the mean DBP level >120 mm Hg were selected for the analysis. The DBP used to define severe pre-eclampsia/eclampsia, in this study, was > 110 mm Hg.
Hypothesis 1:
There is a difference in selected physiological factors associated with maternal mortality due to severe pre-eclampsia/eclampsia between nonsurviving (cases) and surviving (controls) women hospitalised at the MCRH during 1995, 1996 and 1997.
( Table 3 is on the next page.)
The two-tailed test for normal distribution was used to determine the differences in factors for proportions between cases and controls. The hypothesis was rejected for the variable of DBP > 110 mm Hg and supported for a DBP above the mean DBP of 120 mm Hg.
A two-tailed p-value of 0.039 (greater than p-value = 0.025) confirmed that there was no statistical difference in proportions between cases and controls for DBP > 110 mm Hg. However, when the cases and controls were compared for a mean DBP of >120 mm Hg, the results showed a statistically significant difference in proportions (p-value =0.021). The findings indicated that the number of cases that had a mean DBP of >120 mm Hg was higher than the controls. This suggested that hypertension had progressed further in women who died.
Comparison between severe preeclampsia/eclampsia cases and controls by selected aspects of standard of maternity care factor, proportion and pvalue The standard of maternity care factors were analysed using the two-tailed test for normal distribution for differences in proportions between cases and controls for health care factors. The differences imply that a higher proportion of severe pre-eclampsia/eclampsia cases than controls were provided with these aspects of standard maternity care, or that such care was more accurately recorded for cases than for controls.
When the standard of maternity care was analysed regarding variables including emergency care, fluid intake and output recording, follow-up care and documentation of care given, it appeared as if women who died received better care than those who survived in relation to these aspects of care. When this risk was further investigated unexpected findings were revealed.
Women with a DBP > 110 mm Hg and a mean DPB >120 mm Hg, and with omission of emergency care, fluid intake and output recordings, follow-up care and documentation of care were less likely to die from severe pre-eclampsia/eclampsia. The variables of fluid intake and output recording, follow-up care and documentation of care remained significant after a stepwise regression test.
Evidence from this research revealed that preeclampsia/eclampsia was more common among primgravidae, confirming that the first pregnancy is a 
LIMITATIONS OF THE RESEARCH
The major limitation was that data were collected from 
RECOMMENDATIONS
The retrospective obstetric records audit played a central role in providing insight into factors associated with maternal mortality, which is expected to strengthen strategies to reduce maternal mortalities from severe pre-eclampsia/eclampsia in Zimbabwe through regular auditing of care and surveillance. The results of such audits should be discussed at in-service education sessions.
As magnesium sulphate has been shown to reduce the severity of pre-eclampsia/eclampsia and as it was not administered to a single patient, Zimbabwe should urgently revise its policy guidelines to include the safe administration of magnesium sulphate to these patients. Nurses and midwives need to receive the required in-service education to do so safely and effectively. Midwives should be allowed to keep stocks of magnesium sulphate and to administer it to women with impending signs of pre-eclampsia/eclampsia prior to transferring them from clinics to hospitals.
Essential midwifery drugs, including oxytocics, antibiotics, antihypertensives and anti-convulsants (in addition to magnesium sulphate) should be available at all centres rendering midwifery services. Treatment protocols should clearly specify under which circumstances what dosages of these drugs could be administered and these protocols should be discussed during in-service education sessions.
Although the partograph is used to monitor the progress of labour throughout Zimbabwe, its action guidelines need to be researched and adapted to the unique situations in Zimbabwe. For example, critical points of unsatisfactory progress when the patient must be referred to more advanced levels of health care
should be specified taking into account the number of hours the patient is likely to be in transit prior to reaching the secondary or tertiary health care facility. Although the research findings of this retrospective case control study could not substantiate the premise that late arrivals, during advanced stages of complications due to pre-eclampsia/eclampsia, adversely affected the women's chances of survival, this possibility needs to be addressed and accommodated in future policies.
All pregnant women with hyperpyrexia should be tested, 
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